Transfusion Related Acute Lung Injury (TRALI)
Audience: Health Professionals, particularly Respiratory Specialists
FDA alerts health professionals to the risk of Transfusion Related Acute Lung Injury (TRALI) in patients who receive blood products, particularly plasma-containing products. TRALI is a serious pulmonary syndrome that can lead to death if not recognized and treated appropriately. Recognition of symptoms and immediate treatment are imperative.
[October 19, 2001 - Letter - FDA]